Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2008-03-18
2008-03-18
Landsman, Robert S. (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C530S350000
Reexamination Certificate
active
07344843
ABSTRACT:
The present invention relates to the field of metabolic research, in particular the discovery of compounds effective for reducing body mass and useful for treating obesity-related diseases and disorders. The obesity-related diseases or disorders envisioned to be treated by the methods of the invention include, but are not limited to, hyperlipidemia, atherosclerosis, insulin resistance, diabetes, and hypertension. In particular, the invention provides for methods of identifying and using AGONISTS and ANTAGONISTS of PROLIXIN activity, wherein said activity is selected from the group consisting of lipid partitioning, lipid metabolism, and insulin-like activity.
REFERENCES:
patent: 6344441 (2002-02-01), Bihain et al.
patent: 6461821 (2002-10-01), Matsuzawa et al.
patent: 6566332 (2003-05-01), Fruebis et al.
patent: 6579852 (2003-06-01), Fruebis et al.
patent: 6867189 (2005-03-01), Lucas et al.
patent: 6946444 (2005-09-01), Bihain et al.
patent: 6967091 (2005-11-01), Fruebis et al.
patent: 6989367 (2006-01-01), Fruebis et al.
patent: 2002/0151498 (2002-10-01), Bihain et al.
patent: 2003/0092164 (2003-05-01), Gross et al.
patent: 2003/0215836 (2003-11-01), Young et al.
patent: 2003/0224501 (2003-12-01), Young et al.
patent: 2005/0003997 (2005-01-01), Lucas et al.
patent: 2005/0054565 (2005-03-01), Lucas et al.
patent: 2006/0089311 (2006-04-01), Dialynas et al.
patent: 1033134 (2000-09-01), None
patent: WO 99/59618 (1999-11-01), None
patent: WO 00/68380 (2000-11-01), None
patent: WO 00/73448 (2000-12-01), None
patent: WO 01/51645 (2001-07-01), None
patent: WO 02/38766 (2002-05-01), None
Thompson, J.S. et al., “BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFF”Science, Sep. 14, 2001, pp. 2108-2111, vol. 293, No. 5537.
Yan, M. et al. “Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency”Current Biology, Oct. 2, 2001, pp. 1547-1552, vol. 11, No. 19.
U.S. Appl. No. 11/132,814, filed May 19, 2005, claims only.
Briggs Kristen
Dialynas Deno
Lucas John
Chandra Gyan
Landsman Robert S.
Saliwanchik Lloyd & Saliwanchik
Serono Genetics Institute S.A.
LandOfFree
Agonists and antagonists of prolixin for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agonists and antagonists of prolixin for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agonists and antagonists of prolixin for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2788999